Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure

Annals of Oncology

Volumn 19, Issue 1, 2008, Pages 109-114

  Ruano Ravina, Albert ^a,b   Perez Becerra R ^b   Fraga, M ^b   Kelsey, K T ^c   Barros Dios, J M ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Gene p53; Immunohistochemistry; Lung neoplasms; Radon

Indexed keywords

PROTEIN P53; RADON;

ALCOHOL CONSUMPTION; ARTICLE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RESIDENTIAL HOME; RISK FACTOR; SEQUENCE ANALYSIS; SMOKING;

AGED; AIR POLLUTANTS, RADIOACTIVE; AIR POLLUTION, INDOOR; ALCOHOL DRINKING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; COCARCINOGENESIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADON; RESIDENCE CHARACTERISTICS; RISK FACTORS; SMOKING; SPAIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37849054294     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm395     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
3. Radon. IARC Monogr Eval Carcinog Risks Hum 1988; 43: 173-259.
4. EPA. EPA Assessment of Risk from Radon in Homes. EPA 402-R-03-003, United States Environmental Protection Agency. United States Government. 2003.
5. Euratom. 90/143/Euratom: Commission Recommendation of 21 February 1990 on the Protection of the Public Against Indoor Exposure to Radon. 1990 http://eur-lex.europa.eu/LeUriServ/ LexUriserv.do?uri=CELEX:31990H0143:EN:HTML (09 August 2007, date last accessed).
6. Hall EJ, Hei TK. Genomic instability and bystander effects induced by high LET radiation. Oncogene 2002; 22: 7034-7042.
7. Hainaut P, Pfeifer GP. Patterns of p53 G→ T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22(3): 367-374.
8. Hainaut P, Hernandez T, Robinson A et al. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualization tools. Nucleic Acids Res 1998; 26(1): 205-213.
9. Vähäkangas K. Molecular epidemiology of human cancer risk. Methods Mol Med 2003, 74(1): 43-59.
10. Vähäkangas K. TP53 mutations in workers exposed to occupational carcinogens. Hum Mutat 2003; 21: 240-251.
11. Vahakangas KH, Samet JM, Metcalf RA et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 1992; 339: 576-580.
12. Yngveson A, Williams C, Hjerpe A et al. p53 mutations in lung cancer associated with residential radon exposure, Cancer Epidemiol Biomarkers Prev 1999; 8: 433-438.
13. Lo YM, Darby S, Noakes L et al. Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. Lancet 1995; 345: 60.
14. Barros-Dios JM, Barreiro Carracedo MA, Ruano-Ravina A, Figueiras A. Exposure to residential radon and lung cancer risk in Spain: A population-based case-control study. Am J Epidemiol 2002; 156(6): 548-555.
15. Darby S, Hill D, Auvinen A et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. Br Med J 2005; 330: 223-226.
16. Ahrens W, Merletti F. A standard tool for the analysis of occupational lung cancer in epidemiologic studies. Int J Occup Environ Health 1998; 4(4): 236-240.
17. Taylor JA, Watson MA, Deveraux TR et al. P53 mutation hotspot in radon-associated lung cancer. Lancet 1994; 343: 86-87.
18. Hollstein M, Bartsch H, Wesch H et al. p53 gene mutation analysis in tumors of patients exposed to α-particles. Carcinogenesis 1997; 18(3): 511-516.
19. Yang Q, Wesch H, Mueller K-M et al. Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. Br J Cancer 2000; 82(4): 763-765.
20. McDonald J, Taylor J, Watson M et al. P53 and K-ras in radon-associated lung adenocarcinorna. Cancer Epidemiol Biomarkers Prev 1995; 4(7): 791-793.
21. Barros-Dios JM, Ruano-Ravina A, Gastelu-Iturri J, Figueiras A. Factors underlying residential radon concentration. Results from Galicia (Spain). Environ Res 2007; 103(2): 185-190.
22. Robles Al, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene 2002; 21: 6898-6907.
23. Hernandez-Boussard TM, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database. Environ Health Perspect 1998; 106(7): 385-391.
24. Kelsey KT, Hirao T, Schned A et al. A population based study of inmunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer 2004; 90: 1572-1576.
25. Zhou H, Suzuki M, Randers-Pehrson G et al. Radiation risk to low fluences of alpha particles may be greater than we thought. Proc Natl Acad Sci USA 2001; 98(25): 14410-14415.
26. Hagiwara N, Mechanic LE, Trivers GE et al. Quantitative detection of p53 mutations in plasma DNA from tobacco smokers. Cancer Res 2006; 66(16): 8309-8317.
27. Lee JM,Shun CT, Wu MT et al. The associatons of p53 overexpression with p53 codon 72 genetic polymorphisms in esophageal cancer. Mutat Res 2006; 594(1-2): 181-188.
28. Chaves AC, Cherubini K, Herter N et al. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Int J Oncol 2004; 24(2): 295-303.